Surgery Partners, Inc. (NASDAQ:SGRY) Stock Holdings Increased by Holocene Advisors LP

Holocene Advisors LP lifted its stake in shares of Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) by 34.4% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 131,504 shares of the company's stock after buying an additional 33,680 shares during the quarter. Holocene Advisors LP owned 0.10% of Surgery Partners worth $4,240,000 as of its most recent filing with the SEC.

Several other hedge funds have also modified their holdings of the stock. Centiva Capital LP raised its holdings in shares of Surgery Partners by 130.5% during the 3rd quarter. Centiva Capital LP now owns 37,600 shares of the company's stock valued at $1,212,000 after buying an additional 21,290 shares during the period. Point72 Asia Singapore Pte. Ltd. raised its holdings in shares of Surgery Partners by 747.6% during the 3rd quarter. Point72 Asia Singapore Pte. Ltd. now owns 3,831 shares of the company's stock valued at $124,000 after buying an additional 3,379 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in shares of Surgery Partners by 24.1% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 19,233 shares of the company's stock valued at $620,000 after buying an additional 3,729 shares during the period. FMR LLC raised its holdings in shares of Surgery Partners by 3.1% during the 3rd quarter. FMR LLC now owns 18,311,867 shares of the company's stock valued at $590,375,000 after buying an additional 546,869 shares during the period. Finally, Charles Schwab Investment Management Inc. raised its holdings in shares of Surgery Partners by 5.3% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 772,746 shares of the company's stock valued at $24,913,000 after buying an additional 38,810 shares during the period.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on SGRY shares. StockNews.com downgraded Surgery Partners from a "hold" rating to a "sell" rating in a report on Wednesday, August 7th. Benchmark restated a "buy" rating and set a $50.00 price objective on shares of Surgery Partners in a report on Monday, August 26th. KeyCorp initiated coverage on Surgery Partners in a report on Friday, October 11th. They set a "sector weight" rating on the stock. Royal Bank of Canada decreased their target price on Surgery Partners from $49.00 to $35.00 and set an "outperform" rating for the company in a research report on Wednesday, November 20th. Finally, JPMorgan Chase & Co. decreased their target price on Surgery Partners from $38.00 to $28.00 and set a "neutral" rating for the company in a research report on Tuesday. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and six have given a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $37.38.

Surgery Partners Stock Performance

NASDAQ:SGRY traded down $1.06 during midday trading on Thursday, reaching $21.46. 1,872,364 shares of the company traded hands, compared to its average volume of 979,662. Surgery Partners, Inc. has a twelve month low of $21.10 and a twelve month high of $36.92. The company has a current ratio of 1.80, a quick ratio of 1.66 and a debt-to-equity ratio of 0.99. The company has a fifty day moving average price of $28.42 and a 200 day moving average price of $28.17.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last released its quarterly earnings data on Tuesday, November 12th. The company reported $0.19 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.25 by ($0.06). Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. The company had revenue of $770.40 million for the quarter, compared to analyst estimates of $768.99 million. During the same quarter in the prior year, the firm earned $0.15 EPS. The company's revenue for the quarter was up 14.3% compared to the same quarter last year. Sell-side analysts anticipate that Surgery Partners, Inc. will post 0.73 earnings per share for the current fiscal year.

Surgery Partners Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.